Ten markers, namely Podoplanin, Glut-1, Muc-1, Egfr, Igf1r, c-Jun, and n-Ras, from ten articles that included 748 cases of thymoma and 280 cases of thymic carcinoma were selected. This evidence concerns the gene NRAS and thymic carcinoma.